Pouchitis: Pathophysiology and treatment

International Journal of Colorectal Disease

Volumn 13, Issue 5-6, 1998, Pages 196-207

  Kuhbacher T ^a   Schreiber, S ^a   Runkel, N ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Biological response modifying therapies; Pouchitis; Risk factors

Indexed keywords

ANTIINFLAMMATORY AGENT; BIOLOGICAL RESPONSE MODIFIER; CELL ADHESION MOLECULE; NEUTROPHIL CYTOPLASMIC ANTIBODY; OXYGEN RADICAL; SHORT CHAIN FATTY ACID;

CANCER RISK; DISEASE COURSE; FAMILIAL POLYPOSIS; HUMAN; ILEITIS; ILEOANAL ANASTOMOSIS; INFLAMMATION; MEDIATOR; MICROFLORA; PATHOPHYSIOLOGY; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROCTOCOLECTOMY; RECTUM MUCOSA; RECURRENT DISEASE; REVIEW; RISK FACTOR; SMOKING CESSATION; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; COLONIC NEOPLASMS; HUMANS; POSTOPERATIVE COMPLICATIONS; POUCHITIS; PROCTOCOLECTOMY, RESTORATIVE; RISK FACTORS;

EID: 0031730761     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003840050162     Document Type: Review

References (199)

1. Probert CS, Jayanthi V, Rampton DS, Mayberry JF (1996) Epidemiology of inflammatory bowel disease in different ethnic and religious groups: limitations and aetiological clues. Int J Colorectal Dis 11:25-28
2. Stewenius J, Adnerhill I, Anderson H, Ekelund GR, Floren CH, Fork FT, Janzon L, Lindstrom C, Ogren M (1995) Incidence of colorectal cancer and all cause mortality in non-selected patients with ulcerative colitis and indeterminate colitis in Malmo, Sweden. Int J Colorectal Dis 10: 117-122
3. Sher ME, Weiss EG, Nogueras JJ, Wexner SD (1996) Morbidity of medical therapy for ulcerative colitis: what are we really saving? Int J Colorectal Dis 11:287-293
4. Sher ME, Sands LR, Agachan F, Nogueras JJ, Weiss EG, Wexner SD (1996) Morbidity, cost and disability of medical therapy for ulcerative colitis: what are we really saving? Int J Colorectal Dis 11:143
5. Marcello PW, Schoetz DJ, Roberts PL, Murray JJ, Coller JA, Rusin LC, Veidenheimer MC (1996) Evolutionary changes in pathologic diagnosis followoing the ileoanal pouch procedure. Int J Colorectal Dis 11:145
6. Weaver RM, Alexander-Williams J, Keighley MR (1988) Indications and outcome of reoperation for ileostomy complications in inflammatory bowel disease. Int J Colorectal Dis 3:38-42
7. Carlstedt A, Fasth S, Hulten L, Nordgren S, Palselius I (1987) Long-term ileostomy complications in patients with ulcerative colitis and Crohn's disease. Int J Colorectal Dis 2:22-25
8. Isbister WH (1996) Fistula in ano: a surgical audit. Int J Colorectal Dis 11:200
9. Senapati A, Tibbs CJ, Ritchie JK, Nicholls RJ, Hawley PR (1996) Stenosis of the pouch anal anastomosis following restorative proctocolectomy. Int J Colorectal Dis 11:57-59
10. Ozuner G, Hull T, Fazio V, Navaro G (1996) What happens to the pelvic pouch when a fistula develops. Int J Colorectal Dis 11:144
11. Cohen Z, McLeod RS, Stephen W, Stern HS, O'Connor B, Reznick R (1992) Continuing evolution of the pelvic pouch procedure. Ann Surg 216:506-511
12. Pena JP, Gemlo BR, Rothenberger DA (1992) Ileal pouch-anal anastomosis: state of the art. Baillieres Clin Gastroenterol 6:113-128
13. Smith LE (1989) Surgical therapy in ulcerative colitis. Gastroenterol Clin North Am 18:99-110
14. Dozois RR, Goldberg SM, Rothenberger DA, Utsunomiya J, Nicholls RJ, Cohen Z, Hulten LA, Moskowitz RL, Williams NS (1986) Restorative proctocolectomy with ileal reservoir. Int J Colorectal Dis 1:2-19
15. van Duijvendijk P, Slors JFM, Taat CW, Sprangers MAG, Kuijpers JHC, Vasen HFA (1997) The quality of life after ileorectal or ileoanal anastomosis in patients with familial adenomatous polyposis (FAP). Int J Colorectal Dis 12:350-351
16. Björk J, Akerbrant H, Hultcrantz R, Iselius L, Poppen B (1997) Functional outcome after IRA and IPAA in FAP patients. Int J Colorectal Dis 12:359-360
17. Heiskanen I, Järvinen HJ (1997) Functional outcome after colectomy and ileorectostomy versus ileoanal anastomosis in patients with familial adenomatous polyposis. Int J Colorectal Dis 12:363
18. Bouchard S, Belliveau P, Trudel J (1996) Quality of life with an ileal reservoir. Int J Colorectal Dis 11:147
19. Gudgeon AM, Balcon J, Leicester RJ (1996) Quality of life and pouch function following restorative proctocolectomy. Int J Colorectal Dis 11:154
20. Brunel M, Penna C, Tiret E, Parc R (1996) Ileal pouch-anal anastomosis for distal ulcerative colitis. Int J Colorectal Dis 11:154
21. Tonelli F, Batignani G, Ficari F, Mazzoni P, Garcea A, Monaci I (1997) Straight ileoanal anastomosis with multiple ileal myotomies as an alternative to pelvic pouch. Int J Colorectal Dis 12:261-266
22. Bertario L, Sala P, varesco L, Radice P, Presciuttini S, Aste H, Ponz de Leon M, Giarola M, Mareni C, Gismondi V, Eboli M, Spinelli P (1997) The fate of rectal stump after ileorectal anastomosis in FAP. Int J Colorectal Dis 12:350
23. Church J, McGannon E, Hull-Boiner S (1997) Rectal cancer in familial adenomatous polyposis (FAP). A comparison of cancers arising after ileorectal anastomosis (IRA) with those arosing before colon surgery. Int J Colorectal Dis 12:351
24. Weinryb RM, Gustavsson JP, Liljeqvist L, Poppen B, Rossel RJ (1995) A prospective study of the quality of life after pelvic pouch operation. J Am Coll Surg 180:589-595
25. Ziv Y, Church JM, Oakley JR, McGannon E, Fazio VW (1995) Surgery for the teenager with familial adenomatous polyposis: ileo-rectal anastomosis or restorative proctocolectomy? Int J Colorectal Dis 10:6-9
26. Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Rossi SS, Hofmann AF, Gores GJ, Phillips SF (1995) Fecal bile acids, short-chain fatty acids, and bacteria after ileal pouch-anal anastomosis do not differ in patients with pouchitis. Dig Dis Sci 40:1474-1483
27. Kohler LW, Pemberton JH, Zinsmeister AR, Kelly KA (1991) Quality of life after proctocolectomy. A comparison of Brooke ileostomy, Kock pouch, and ileal pouch-anal anastomosis. Gastroenterology 101:679-684
28. Kohler L, Troidl H (1995) The ileoanal pouch: a risk-benefit analysis. Br J Surg 82:443-447
29. Heyvaert G, Penninckx F, Filez L, Aerts R, Kerremans R, Rutgeerts P (1994) Restorative proctocolectomy in elective and emergency cases of ulcerative colitis. Int J Colorectal Dis 9:73-76
30. Isbister WH, Prasad J (1997) Emergency large bowel surgery: a 15-year audit Int J Colorectal Dis 12:285-290
31. Tan HT, Connolly AB, Morton D, Keighley MR (1997) Results of restorative proctocolectomy in the elderly. Int J Colorectal Dis 12:319-322
32. Oresland T, Fasth S, Nordgren S, Hulten L (1989) The clinical and functional outcome after restorative proctocolectomy. A prospective study in 100 patients. Int J Colorectal Dis 4: 50-56
33. Pescatori M, Mattana C (1990) Factors affecting anal continence after restorative proctocolectomy. Int J Colorectal Dis 5:213-218
34. Matzel KE, Stadelmaier U, Muehldorfer S, Hohenberger W (1997) Continence after colorectal reconstruction following resection: impact of level of anastomosis. Int J Colorectal Dis 12:82-87
35. Ryhammer AM, Laurberg S, Sorensen FH (1997) Effects of age on anal function in normal women. Int J Colorectal Dis 12:225-229
36. Favetta U, Amato A, Interisano A, Pescatori M (1996) Clinical, manometric and sonographic assessment of the anal sphincters. A comparative prospective study. Int J Colorectal Dis 11:163-166
37. Bauer JJ, Gorfine SR, Gelernt IM, Harris MT, Kreel I (1996) Restorative proctocolectomy in patients over fifty years old. Int J Colorectal Dis 11:146
38. Scott HJ, McLeod RS, Blair J, O'Connor B, Cohen Z (1996) Ileal pouch-anal anastomosis: pregnancy, delivery and pouch function. Int J Colorectal Dis 11:84-87
39. Scott HJ, McLeod RS, Blair J, Cohen Z (1996) Ileal pouchanal anastomosis: presnancy, delivery and pouch function. Int J Colorectal Dis 11:154
40. Lavery IC, Sirimarco MT, Ziv Y, Fazio VW (1995) Anal canal inflammation after ileal pouch-anal anastomosis. The need for treatment. Dis Colon Rectum 38:803-806
41. Fonkalsrud EW (1995) Surgery for pediatric ulcerative colitis. Curr Opin Pediatr 7:323-327
42. Sarigol S, Caulfield M, Wyllie R, Alexander F, Lavery I, Steffen R, Kay M, Michener W (1996) Ileal pouch-anal anastomosis in children with ulcerative colitis. Inflamm Bowel Dis 2:82-87
43. Fischer JE, Nussbaum MS, Martin LW, Warner BW, Flesch L, Staneck JL, Niemer E, Bjornson HS, Thompson R, McFadden DW (1993) The pull-through procederes: technical factors in influencing outcome, with emphasis on pouchitis. Surgery 114:828-834
44. Kamm MA (1997) Chronic pelvic pain in women - gastroenterological, gynaecological or psychological? Int J Colorectal Dis 12:57-62
45. Rieger N, sarre R, Wattchow D, McCall J, Cooper S, Rich C (1996) Pelvic floor training for faecal incontinence. Int J Colorectal Dis 11:141
46. Korsgen S, Keighley MR (1997) Causes of failure and life expectancy of the ileoanal pouch. Int J Colorectal Dis 12:4-8
47. Mikkola K, Luukkonen P, Jarvinen HJ (1995) Long-term results of restorative proctocolectomy for ulcerative colitis. Int J Colorectal Dis 10:10-14
48. Svaninger G, Nordgren S, Oresland T, Kulten L (1993) Incidence and characteristics of pouchitis in the Kock continent ileostomy and the pelvic pouch. Scand J Gastroenterol 28:695-700
49. Michelassi F, Stella M, Block GE (1993) Prospective assessment of functional results after ileal J pouch-anal restorative proctocolectomy. Arch Surg 128:889-894
50. Fazio VW, Ziv Y, Church JM, Oakley JR, Lavery IC, Milsom JW, Schroeder TK (1995) Ileal pouch-anal anastomosis complications and function in 1005 patients. Ann Surg 222: 120-127
51. Fengler SA, Nelson RL, Pearl RK, Abcarian H, Orsay CP (1995) Pull-through procedures performed months to years after permanent proctectomy. Dis Colon Rectum 38:294-296
52. McIntyre PB, Pemberton JH, Wolff BG, Dozois RR, Beart RW Jr (1995) Indetermmante colitis. Long-term outcome in patients after ileal pouch-anal anastomosis. Dis Colon Rectum 38: 51-54
53. Buhr HJ, Heuschen UA, Stern J, Herfarth C (1994) Technique and results of the ileoanal pouch after proctocolectomy. Zentralbl Chir 119:867-877
54. Ecker KW, Schmid T, Haberer M, Hildebrandt U, Feifel G (1994) Experiences with the Kock continent ileostomy. Zentralbl Chir 119:851-861
55. Vecchi M, Gionchetti R, Bianchi MB, Belluzzi A, Meucci G, Campieri M, de Franchis R (1994) p-ANCA and development of pouchitis in ulcerative colitis patients aafter proctocolectomy and ileoanal pouch anastomosis. Lancet 344:1168
56. Pang AS, Chung MR, Lee KK, Schraut WH (1994) An analysis of 50 cases of restorative proctocolectomy. Ann Acad Med Sinsapore 23:76-82
57. Shamberger RC, Lillehei CW, Nurko S, Winter HS (1994) Anorectal function in children after ileoanal pull-through. J Pediatr Surg 29:329-332
58. Davis C, Alexander F, Lavery I, Fazio VW (1994) Results of mucosal proctectomy versus extrarectal dissection for ulcerative colitis and familial polyposis in children and young adults. J Pediatr Surg 29:305-309
59. Sugerman HJ, Newsome HH (1994) Stapled ileoanal anastomosis without a temporary ileostomy. Am J Surg 167:58-65
60. Daude F, Penna C, Tiret E, Frileux P, Hannoun L, Nordlinger B, Parc R (1994) Results of ileoanal anastomosis with mucosectomy and "J" pouch in hemorrhagic rectocolitis. Gastroenterol Clin Biol 18:462-468
61. Solomon MJ, McLeod RS, O'Connor BI, Cohen Z (1995) Assessment of peripouch inflammation after ileoanal anastomosisi using endoluminal ultrasonoaraphy. Dis Colon Rectum 38:182-187
62. Rauh SM, Schoetz DJ Jr, Roberts PL, Murray JJ, Coller JA, Veidenheimer MC (1991) Pouchitis: is it a wastebasket diagnosis? Dis Colon Rectum 34:685-689
63. Hurst RD, Molinari M, Chung TP, Rubin M, Michelassi F (1996) Prospective study of the incidence, timing, and treatment of Pouchitis in 104 consecutive Patients after restorative protocolectomy. Arch Surg 131:497-500
64. Orsoni P, Berdah SV, Bouvier M, Grimaud JC, Picaud R (1997) Post-operanve faecal continence in patients with ulcerative colitis after ileo-anal anastomosis with preservation of the transitional zone: a report from a low-incidence region. Int J Colorectal Dis 12:209-213
65. Landi E, Fianchini A, Landa L, Marmorale C, Corradini G, De Luca S, Piloni V (1990) Proctocolectomy and stapled ileo-anal anastomosis without mucosal proctectomy. Int J Colorectal Dis 5:151-154
66. Gozzotti G, Poggioli G, Marchetti F, Laureti S, Grazi GL, Mastrorilli M, Selleri S, Stocchi L, DiSimone M (1994) Functional outcome in handsewn versus stapled ileal pouch-anal anastomosis. Am J Surg 168:325-329
67. Slors JF, Ponson AE, Taat CW, Bosma A (1995) Risk of residual rectal mucosa after proctocotectomy and ileal pouch-anal reconstruction with the double-stapling technique. Postoperative endoscopic follow-up study. Dis Colon Rectum 38: 207-210
68. Sequens R (1997) Cancer in the anal canal (transitional zone) after restorative proctocolectomy with stapled ileal pouch-anal anastomosis. Int J Colorectal Dis 12:254-255
69. Esteve M, Mallolas J, Klaassen J, Abadlacruz A, Gonzalezhuix F, Cabre E, Fernandezbanarez F, Bertran X, Condom E, Martirague J, Gassull MA (1996) Antineutrophil cytoplasmic antibodies in sera from colectomised ulcerative Colitis Patients and ist Relation to the presence of Pouchitis. Gut 38:894-898
70. Sandborn WJ, Landers CJ, Tremaine WJ, Targan SR (1995) Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis. Am J Gastroenterol 90:740-747
71. Aisenberg J, Wagreich J, Shim J, Almer S, Peen E, Heimann T, Gelernt IM, Greenstein A, Rubin P, Harpaz N et al (1995) Perinuclear anti-neutrophil cytoplasmic antibody and refractory pouchitis. A case control study. Dig Dis Sci 40: 1866-1872
72. Yang P, Oreland T, Jarnerot T, Hulten L, Danielsson D (1996) Perinuclear antineutrophilic cytoplasmic antibody in pouchitis after proctocolectomy with ileal pouch anal anastomosis for ulcerative colitis. Scand J Gastroenterol 31:594-598
73. Penna C, Dozois R, Tremaine W, Sandborne N, Larusso N, Schleck G, Ilstrup D (1996) Pouchitis after ileal pouch anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 38:234-239
74. Zins BJ, Sandborn WJ, Penna CR, Landers CJ, Targan SR, Tremaine WJ, Wiesner RH, Dozois RR (1995) Pouchitis disease course after orthotopic liver transplantation in patients with sclerosing cholansitis and ileal pouch anal anastomosis. Am J Gastroenterol 90:2127-2181
75. Merrett MN, Mortensen N, Kettlewell M, Jewell DO (1996) Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis. Gut 38:362-364
76. Thomas GA, Rhodes J, Green JT (1998) Inflammatory bowel disease and smoking - a review. Am J Gastroenterol 93: 144-149
77. Srivasta ED, Newcombe RG, Rhodes J, Avramidis P, Mayberry JF (1993) Smoking and ulcerative colitis: a community study. Int J Colorectal Dis 8:71-74
78. Calkins BM (1989) A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 34:1841-1854
79. Cope GF, Heatley RV, Kelleher J, Lee PN (1987) Cigarette smoking and inflammatory bowel disease: a review. Hum Toxicol 6: 189-193
80. McCourtney JS, Baxter JN, Finlay IG, Muir TC (1996) The ileum used to make the ouch in ulcerative colitis may be pharmacologically abnormal. Int J Colorectal Dis 11: 144
81. Goldberg PA, Herbst F, Beckett CG, Martelli B, Kontakou M, Talbot IC, Ciclitira PJ, Nicholis RJ (1996) Leucocyte typing, cytokine expression, and epithelial turnover in the ileal pouch in patients with ulcerative colitis and familial adenomatous polyposis. Gut 38:549-553
82. MacDonald TT, Spencer J (1988) Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine. J Exp Med 167:1341-1349
83. Lionetti P, Breese E, Braegger CP, Murch SH, Taylor J, MacDonald TT (1993) T-cell activation can induce either mucosal destruction or adaptation in cultured human fetal small intestine. Gastroenterology 105:373-381
84. Shepherd NA, Healey CJ, Warren BF, Richman PI, Thomson WH, Wilkinson SP (1993) Distritubtion of mucosal pathology and an assessment of colonic phenotypic change in the pelvic ileal reservoir. Gut 34: 101-105
85. Latella G, Fonti R, Caprilli R, Marchegaiano A, Magltocca F, Das KM, Gambus G, Sambuy Y (1996) Characterization of the mucins produced by normal human colonocytes in primary culture. Int J Colorectal Dis 11:76-83
86. Carraro PG, Talbot IC, Nicholis JR (1998) Patterns of distribution of endoscopic and histological changes in the ileal reservoir after restorative proctocolectomy for ulcerative colitis. A long-term follow-up study. Int J Colorectal Dis 13:103-107
87. de Silva HJ, Millard PR, Soper N, Kettlewell M, Mortensen N, Jewell DP (1991) Effects of the faecal stream and stasis on the ileal pouch mucosa. Gut 32:1166-1169
88. de Silva HJ, Millard PR, Kettlewell M, Mortensen N, Prince C, Jewell DP (1991) Mucosal characteristics in pelvic ileal pouches. Gut 32:1160-1165
89. de Silva HJ, de Angelis CP, Soper N, Kettlewell M, Mortensen NJ, Jewell DP (1991) Lymphocytes and macrophage subpopulations in pelvic ileal pouches. Br J Surg 78:1039-1044
90. Apel R, Cohen Z, Andrews CW Jr, McLeod R, Steinhart H, Odze RD (1994) Prospective evaluation of early morphological changes in pelvic ileal pouches. Gastroenterology 107: 435-443
91. Merrett MN, Soper N, Mortensen N, Jewell DP (1996) Intestinal permeability in the ileal pouch. Gut 39:226-230
92. 111In-labeled granulocytes. Gastroenterology 104:981-988
93. Boerr LA, Sambuelli AM, Sugai E, Graziano A, Valero J, Kogan Z, Bai J (1995) Faecal alpha I-antitrypsin concentration in the diagnosis and management of patients with pouchitis. Eur J Gastroenterol Hepatol 7:129-133
94. De Silva HJ, Jones M, Prince C, Kettlewell M, Mortensen MJ, Jewell DP (1991) Lymphocyte and macrophage subpopulations in pelvic ileal pouches. Gut 32:1160-1165
95. Gertner DJ, Rampton DS, Madden MV, Talbot IC, Nicholis RJ, Lennard-Jones JE (1994) Increased leukotriene B4 release from ileal pouch mucosa in ulcerative colitis compared with familial adenomatous polyposis. Gut 35: 1429-1432
96. Chaussade S, Denizot Y Valleur P, Nicoli J, Raibaud P, Guerre J, Hautefeuille P, Coururier D, Benveniste J (1991) Presence of PAF-acether in stool of patients with pouch ileoanal anastomosis and pouchitis. Gastroenterology 100:1509-1514
97. Schreiber S, Raedler A, Stenson WF, MacDermott RP (1992) The immunology of inflammatory bowel disease. Gastroenterol Clin North Am 21:451-502
98. Malizia G, Calabrese A, Cottone M, Raimondo M, Trejdosiewicz LK, Smart CJ, Oliva L, Pagliaro L (1991) Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease. Gastroenterology 100:150-159
99. Koizumi M, King N, Lobb R, Benjamin C, Podolsky DK (1992) Expression of vascular adhesion molecules in inflammatory bowel disease. Gastroenterology 103:840-847
100. Albelda SM, Smith CW, Ward PA (1994) Adhesion molecules and inflammatory injury. FASEB J 8:504-512
101. Jones SC, Banks RE, Haidar A, Gearing AJ, Hemingway IK, Ibbotson SH Dixon MF, Axon AT (1995) Adhesion molecules in inflammatory bowel disease. Gut 36:724-730
102. Malizia G, Calabrese A, Cottone M, Raimondo M, Trejdosiewicz LK, Smart CJ, Oliva L, Pagliaro L (1991) Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease. Gastroenterology 100: 150-159
103. Koizumi M, King N, Lobb R, Benjamin C, Podolsky DK (1992) Expression of vascular adhesion molecules in inflammatory bowel disease. Gastroenterology 103:840-847
104. Oshitani N, Campbell A, Bloom S, Kitano A, Kobayashi K, Jewell DP (1995) Adhesion molecule expression on vascular endothelium and nitroblue tetrazolium reducing activity in human colonic mucosa. Scand J Gastroenterol 30: 915-920
105. Patel RT, Pall AA, Adu D, Keighley MRB (1995) Circulating soluble adhesion molecules in inflammatory bowel disease. Eur J Gastroenterol Hepatol 7:1037-1041
106. Rhodes JM, Bartholomew TC, Jewell DP (1981) Inhibition of leukocyte moulity by drugs used in ulcerative colitis. Gut 22:642-647
107. Rhodes JM, Potter BJ, Brown DJC, et al (1982) Serum inhibitors of leukocyte chomtaxis in Crohn's disease and ulcerative colitis. Gastroenterology 82: 1327-1334
108. Wandall JH, Binder V (1982) Leukocyte function in ulcerative colitis. Gut 23:758-765
109. Morain CO, Segal AA, Walker D, et al (1981) Abnormalities of neutrophil function do not cause the migration defect in Crohn's disease. Gut 22:817-822
110. Grisham MB, Granger DN (1988) Neutrophil mediated mucosal injury. Role of reactive oxygen metabolites. Dig Dis Sci 33:6S-15S
111. Faden H, Rossi TM (1985) Chemiluminescent response of neutrophiles from patients with inflammatory bowel disease. Dig Dis Sci 30: 139-142
112. Anton PA, Targan SR, Shanahan F (1989) Increased neutrophil receptors for and response to the pro-inflammatory bacterial peptide formyl-methionyl-leucyl-phenylalanine in Crohn's disease. Gastroenterology 97:20-28
113. Kelleher D, Feighery C, Weir DG (1990) Chemiluminescence by polymorphonuclear leucocyte subpopulations in chronic inflammatory bowel disease. Influence of the cell separation procedure. Digestion 45: 158-165
114. Baldassano RN, Schreiber S, Johnston RB, Muraki T, MacDermott RP (1993) Monocytes of patients with Crohn's disease are primed for accentuated release of toxic oxygen metabolites: possible role for endotoxin. Gastroenteroloey 105:60-66
115. Griga T, Tromm A, Schwegler U, May B (1995) Enhanced superoxide anion release of normal neutrophil granulocytes primed with sera of patients with inactive inflammatory bowel disease. Z Gastroentrol 33:345-348
116. Andus T, Gross V, Caesar I, Krumm D, Hosp J, Gerok W, Scholmerich J (1993) PMN-elastase in assessment of patients with inflammatory bowel disease. Dig Dis Sci 38: 1638-1644
117. Adeyemi EO, Hodgson HJ (1992) Faecal elastase reflects disease activity in active ulcerative colitis. Scand J Gastroenterol 27: 139-142
118. Southey A, Tanaka S, Murakami T, Miyoshi H, Ishizuka T, Sugiura M, Kawashima K, Sugita T (1997) Pathophysiological role of nitric oxide in rat experimental colitis. Int J Immunopharmacol 19:669-676
119. Gupta SK, Fitzgerald JF, Chong SK, Croffie JM, Garcia JG (1998) Expression of inducible nitric oxide synthase (iNOS) mRNA in inflamed esophageal and colonic mucosa in a pediatric population. Am J Gastroenterol 93:795-798
120. Kimura H, Hokari R, Miura S, Shigematsu T, Hirokawa M, Akiba Y, Kurose I, Higuchi H, Fujimori H, Tsuzuki Y, Serizawa H, Ishii H (1998) Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis. Gut 42: 180-187
121. Rachmilewitz D, Eliakim R, Ackerman Z, Karmeli F (1998) Direct determination of colonic nitric oxide level - a sensitive marker of disease activity in ulcerative colitis. Am J Gastroenterol 93:409-412
122. Tomita R, Tanjoh K (1998) Role of nitric oxide in the colon of patients with ulcerative colitis. World J Surg 22:88-91
123. Ikeda I, Kasajima T, Ishiyama S, Shimojo T, Takeo Y, Nishikawa T, Kameoka S, Hiroe M, Mitsunaga A (1997) Distribution of inducible nitric oxide synthase in ulcerative colitis. Am J Gastroenterol 92: 1339-1341
124. Mahida YR, Wu K, Jewell DP (1989) Enhanced production of interieukin 1-βby mononuclearcells isolated frommucosa with active ulcerative colitis or Crohn's disease. Gut 30:835-838
125. Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D (1990) Role of interleukin 1 in inflammatory bowel disease - enhanced production during active disease. Gut 31:686-689
126. Brynskov J, Tvede N, Andersen CB, Vilien M (1992) Increased concentrations of interieukin 1β, interleukin 2, and soluble interleukin-2 receptors in endoscopic mucosal biopsy specimens with active inflammatory bowel disease. Gut 33:55-58
127. Pullman WE, Elsbury S, Masanobu K, Hapel AJ, Doe WF (1992) Enhanced mucosal cytokine production in inflammatory bowel disease. Gastroenterology 102:529-537
128. Reinecker H-C, Steffen M, Witthoeft T, Pflueger I, Schreiber S, MacDermott RP, Raedler A (1993) Enhanced Secretion of tumor necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 94: 174-181
129. Stevens C, Walz G, Singaram C, Lipman ML, Zanker B, Muggia A, Antonioli D, Peppercorn MA, Strom TB (1992) Tumor necrosis factor-a, interlieukin-1β and interleukin 6 expression in inflammatory bowel disease. Dig Dis Sci 37:818-826
130. Isaacs KL, Sartor RB, Haskill S (1992) Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 103: 1587-1595
131. Woywodt A, Neustock P, Kruse A, Schwarting K, Ludwig D, Stange EF, Kirchner H (1994) Cytokine expression in intestinal mucosal biopsies. In situ hybridisation of the mRNA for interleukin-1 beta, interleukin-6 and tumour necrosis factor-alpha in inflammatory bowel disease. Eur Cytokine Netw 5:387-395
132. Satsangi J, Wolstencroft RA, Cason J (1987) Interleukin-1 in Crohn's disease. Clin Exp Immunol 67:594-605
133. Schreiber S, Heinig T, Panzer U, Reinking R, Bouchard A, Stahl PD et al (1995) Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease. Gastroenterology 108:21-33
134. Schreiber S, Heinig T, Thiele HG, Raedler A (1995) Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 108: 1434-1444
135. Keranen U, Jarvinen H, Karkkainen P, Kiviluoto T, Kivilaakso E, Soinila S (1996) Substance P - an underlying factor for pouchitis? Prospective study of substance P - and vasoactive intestinal polypeptide-immunoreactive innervation and mast cells. Dig Dis Sci 41: 1665-1671
136. Watanabe T, Kubota Y, Muto T (1998) Substance P containing nerve fibers in ulcerative colitis. Int J Colorectal Dis 13:61-67
137. Anton PA, Shanahan F (1998) Neuroimmunomodulation in inflammatory bowel disease. How far from "bench" to "bedside"? Ann N Y Acad Sci 840:723-734
138. Mahida YR, Patel S, Giochetti P, Vaux D, Jewell DP (1989) Macrophage subpopulations in lamina propria of normal and inflamed colon and terminal ileum. Gut 30:826-834
139. Campbell AP, Merrett MN, Kettlewell M, Mortensen NJ, Jewell DP (1994) Expression of colonic antigens by goblet and columnar epithelial cells in ileal pouch mucosa: their association with inflammatory change and faecal stasis. J Clin Pathol 47:834-838
140. Schreiber S, Raedler A, Conn AF, Rombeau JL, MacDermott RP (1992) Increased release of soluble interleukin-2 receptor by colonic lamina propria mononuclear cells in inflammatory bowel disease. Gut 32:236-241
141. Saxon A, Shanahan F, Landers C, Ganz T, Targan S (1990) A distinct subset of antineutrophil cytoplasmatic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 86:202-210
142. Rump JA, Scholmerich J, Gross V, Roth M, Helfesrieder R, Rautmann A, Ludemann J, Gross WL, Peter HH (1990) A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiology 181:406-413
143. Halbwachs-Mecarelli L, Nusbaum P, Noel LH, Reumaux D, Erlinger S, Grunfeld JP, Lesavre P (1992) Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 90:79-84
144. Savige JA, Davies DJ, Gatenby PA (1994) Anti-neutrophil cytoplasmic antibodies (ANCA): their detection and significance: report from workshops. Pathology 26: 186-193
145. Reumaux D, Meziere C, Colombel JF, Duthilleul P, Muller S (1995) Distinct production of autoantibodies to nuclear components in ulcerative colitis and in Crohn's disease. Clin Immunol Immunopathol 77:349-357
146. Hardarson S, Labrecque DR, Mitros FA, Neil GA, Goeken JA (1993) Anti-neutrophil cytoplasmic antibody in inflammatory bowel disease High prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis. Am J Clin Pathol 99:277-281
147. Oudkerk-Pool M, Bouma G, Meuwissen SG, von-Blomberg BM, van de Merwe JP, Deville WL, Fonk JC, Pena AS (1995) Serological markers to differentiate between ulcerative colitis and Crohn's disease. J Clin Pathol 48:346-350
148. Broekroelofs J, Mulder AH, Nelis GF, Westerveld BD, Tervaert JW, Kallenberg CG (1994) Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD). Relation to disease pattern and disease activity. Dig Dis Sci 39:545-549
149. Lindgren S, Floren CH, Lindhagen T, Stark M, Stewenius J, Nassberger L (1995) Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission. Eur J Gastroenterol Hepatol 7:563-568
150. Targan SR, Landers CJ, Cobb L, McDermott RP, Vidrich A (1995) Perinulcear anti-neutrophil cytoplasmic antibodies are spontaneously produced by mucosal B cells of ulcerative colitis patients. J Immunol 115:3262-3267
151. Aitola P, Miettinen A, Mattila A, Matikainen M, Soppi E (1995) Effect of proctocolectomy on serum antineutrophil cytoplasmic antibodies in patients with chronic ulcerative colitis. J Clin Pathol 48:645-647
152. Haagsma EB, Mulder AH, Gouw AS, Horst G, Meerman L, Slooff MJ, Kallenberg CG (1993) Neutrophil cytoplasmic autoantibodies after liver transplantation in patients with primary sclerosing cholangitis J Hepatol 19:8-14
153. Vecchi M, Gionchetti P, Bianchi MB, Belluzzi A, Meucci G, Camperi M, de Franchis R (1994) p-ANCa and development of pouchitis in ulcerative colitis patients after protocolectomy and ileoanal pouch anastomosis. Lancet 344:886-887
154. Aisenberg J, Wagreich J, Shim J, Aimer S, Peen E, Heimann T, Gelernt IM, Greenstein A, Rubin P, Harpaz N (1995) Perinuclear anti-neutrophil cytoplasmic antibody and refractory pouchitis. A case-control study. Dig Dis Sci 40: 1866-1872
155. Murray FE, O'Brien MJ, Birkeu DH, Kennedy SM, LaMont JT (1987) Diversion colitis. Pathologic findings in a resected sigmoid colon and rectum. Gastroenterology 93: 1404-1408
156. Agarwal VP, Schimmel EM (1989) Diversion colitis: a nutritional defienciency. Nutr Rev 47:257-261
157. Bühner S, Nagel E, Korber J, Vogelsang H, Linn T, Pichlmayr R (1994) Ileal and colonic fatty acid profiles in patients with active Crohn's disease. Gut 35: 1424-1428
158. Sagar PM, Taylor BA, Godwin P, Holdsworth PJ, Johnston D, Lewis W, Miller A, Quirke P, Williamson M (1995) Acute pouchitis and defienciencies of fuel. Dis Colon Rectum 38:488-493
159. Clausen MR, Tvede M, Mortensen PM (1992) Short chain fatty acids in pouch contents from patients with and without pouchitis after ileal pouch-anal anstomosis. Gastroenterology 103: 1144-1153
160. Finnie IA, Taylor BA, Rhodes JM (1993 ) Ileal and colonic epithelial metabolism in quiescent ulcerative colitis: increased glutamine metabolism in distal colon but no defect in butyrate metabolism. Gut 34: 1552-1558
161. Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Rossi SS, Hofmann AF, Gores GJ, Philipps SF (1995) Fecal bile acids, short-chain fatty acids, and bacteria after ileal pouch-anal anastomosis do not differ in patients with pouchitis. Dig Dis Sci 40: 1474-1483
162. Ruseler van Embden JG, Schouten WR, van Lieshout LM (1994) Pouchitis: result of microbial imbalance? Gut 35:659-664
163. McLeod RS, Antonioli D, Cullen J, Dvorak A, Onderdonk A, Silen W, Blair JE, Monahan-Earley R, Cisneros R, Cohen Z (1994) Histologic and microbiologic features of biopsy samples from patients with normal and inflamed pouches. Dis Colon Rectum 37:26-31
164. Santavirta J, Mattila J, Kokki M, Matikainen M (1991) Mucosal morphology and faecal bacteriology after ileoanal anastomosis. Int J Colorectal Dis 6:38-41
165. Onderdonk AB, Dvorak AM, Cisneros RL, McLeod RS, Antionoli D, Silen W, Blair JE, Monahan-Earley RA, Cullen J, Cohen Z (1992) Microbiologic assessment of tissue biopsy samples from ileal pouch patients. J Clin Microbiol 30: 312-317
166. Lobo AJ, Sagar PM, Rothwell J, Quirke P, Godwin P, Johnston D, Axon AT (1993) Carriage of adhesive Escherichia coli after restorative proctocolectomy and pouch anal anastomosis: relation with functional outcome and inflammation. Gut 34: 1379-1383
167. Duchmann R, Kaiser I, Herrmann E, Mayet W, Ewe K, Meier zum Büschenfelde KH (1995) Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 102:448-455
168. Santavirta J (1991) Lactulose hydrogen and [14C]xylose breath tests in patients with ileoanal anastomosis. Int J Colorectal Dis 6:208-211
169. Elson CO, Sartor RB, Tennyson GS, Riddell RH (1995) Experimental models of inflammatory bowel disease. Gastroenterology 109: 1344-1367
170. Swidsinski A, Khilkin M, Kerjaschki D, Schreiber S, Ortner M, Weber J, Lochs H (1998) Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology 115:281-286
171. Brentnall TA, Haggitt RC, Rabinovitch PS, Kimmey MB, Bronner MP, Levine DS, Kowdley KV, Stevens AC, Crispin DA, Edmond M, Rubin CE (1996) Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 110:331-338
172. Veress B, Reinholt FP, Lindquist K, Lofberg R, Liljequist L (1995) Long-term histomorphological surveillance of the pelvic ileal pouch: dysplasia develops in a subgroup of patients. Gastroenterology 109: 1381-1383
173. Setti-Carraro P, Talbot IC, Nicholls RJ (1994) Long term appraisal of the histologic appearances of the ileal reservoir mucosa after restorative proctocoloectomy for ulcerative colitis. Gut 35: 1721-1727
174. Kollmorgen CF, Nivatvongs S, Dean PA, Dozois RR (1996) Long-term causes of death following ileal pouch-anal anstomosis. Dis Colon Rectum 39:525-528
175. Stern H, Walfisch S, Mullen B, Mcleod RS, Cohen Z (1990) Cancer in an ileoanal reservoir: a new late complication? Gut 31:473-475
176. Von Herbay A, Stern J, Herfarth C (1996) Pouch anal cancer after restorative proctocolectomy for familial adenomatous polyposis. Am J Surg Pathol 20:995-999
177. Church J, Wu J, McGannon E (1997) Ileal pouch-anal anastomosis does not reduce the need for endoscopic surveillance in patients with familial adenomatous polyposis. Int J Colorectal Dis 12:351
178. Heiskanen I, Jarvinen HJ (1997) Fate of the rectal stump after colectomy and ileorectal anastomosis for familial adenomatous polyposis. Int J Colorectal Dis 12:9-13
179. Madden MV, McIntyre AS, Nicholls RJ (1994) Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci 39: 1193-1196
180. Nygaard K, Bergan T, Bjorneklett A, Hoverstad T, Lassen J, Aase S (1994) Topical metronidazol treatment in pouchitis. Scand J Gastroenterol 29:462-467
181. Kmiot WA, Youngs D, Tudor R, Thompson R, Keighley MR (1993) Mucosal morphology, cell proliferation and faecal bacteriology in acute pouchitis. Br J Surg 80: 1445-1449
182. Gionchetti P, Rizello F, Venturi A, Ferretti M, Brignola C, Peruzzo S, Poggioli G, Campieri M (1997) Antibiotic association in patients with chronic treatment-resistant pouchitis. Gastroenterology 112: A1105
183. Winter TA, Dalton HR, Merrett MN, Campell A, Jewell DP (1993) Cyclosporine A retention enemas in refractory distal ulcerative colitis and "pouchitis." Scand J Gastroenterol 28:701-704
184. Sandborn WJ, Tremaine WJ, Schroeder KW, Batts KP, Lawson GM, Steiner BL, Harrison JM, Zinsmeister AR (1994) A placebo controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis. Gastroenterology 106: 1429-1435
185. Levin KE, Pemberton JH, Philipps SF, Zinsmeister AR, Pezim ME (1992) Role of oxygen free radicals in the etiology of pouchitis. Dis Colon Rectum 35:452-456
186. Wischmeyer P, Pemberton JH, Philipps SF (1993) Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study. Mayo Clin Proc 68:978-981
187. Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Philipps SF (1994) Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc 69:409-415
188. Pfeifer J, Oliveira L, Park UC, Gonzalez A, Agachan F, Wexner SD (1997) Are interpretations of video defecographies reliable and reproducible? Int J Colorectal Dis 12:67-72
189. Sailer M, Leppert R, Kraemer M, Fuchs KH, Thiede A (1997) The value of endorectal ultrasound in the assessment of adenomas, T1 - and T2-carcinomas. Int J Colorectal Dis 12:214-219
190. Awad RA, Martin J, Guevara M, Ramos R, Noguera JL, Camacho S, Santiago R, Ramirez JL, Toriz A (1997) Defaecography in patients with irritable bowel syndrome and healthy volunteers. Int J Colorectal Dis 12:91-94
191. Meagher AP, Kennedy ML, Lubowski DZ (1996) Rectal mucosal electrosensitivity - what is being tested? Int J Colorectal Dis 11:29-33
192. Rafaelsen SR, Kronborg O, Fenger C, Drue H (1996) Comparison of two techniques of transrectal ultrasonography for the assessment of local extent of polypoid tumours of the rectum. Int J Colorectal Dis 11: 183-186
193. Awad RA, Martin J, Cal y Major M, Noguera JL, Ramos R, Amezcua C, Camacho S, Santiago R, Ramirez JL, Castro J (1998) Transrectal ultrasonography: relationship with anorectal manometry, electromyography and sensitivity tests in irritable bowel syndrome. Int J Colorectal Dis 13:82-87
194. Scholefield JH, Berry DP, Armitage NC, Wastie ML (1997) Magnetic resonance imaging in the management of fistula in ano. Int J Colorectal Dis 12. 276-279
195. Piloni V, Bassotti G, Fioravanti P, Amadio L, Montesi A (1997) Dynamic imaging of the normal pelvic floor. Int J Colorectal Dis 12:246-253
196. Zbar A, DeSouza N, Puni R, Bydder G, Kmiot W (1996) Magnetic resonance imaging (MRI) of anal sphincter sepsis with an internal coil. Int J Colorectal Dis 11: 135
197. van Deventer SJ (1997) Immunology in medical practice. IV. Inflammatory bowel diseases: pathogenic starting points for specific therapy. Ned Tijdschr Geneeskd 141: 1956-1959
198. Schreibers, Nikolaus S, Hampe J (1998) Activation of nuclear factor kappa B inflammatory bowel disease. Gut 42:477-484
199. Petersen TI, Kissmeyer-Nielsen P, Flyvbjerg A, Laurberg S, Christensen (1996) Effect of insulin-like growth factor I (IGF-I) administration on the healing of colonic anastomoses in rats. Int J Colorectal Dis 11: 19-24